These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11257277)

  • 21. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin.
    Moczulski DK; Grzeszczak W; Gawlik B
    Med Sci Monit; 2001; 7(3):441-3. PubMed ID: 11386022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemochromatosis (HFE) genotype and atherosclerosis: Increased susceptibility to iron-induced vascular damage in C282Y carriers?
    Engberink MF; Povel CM; Durga J; Swinkels DW; de Kort WL; Schouten EG; Verhoef P; Geleijnse JM
    Atherosclerosis; 2010 Aug; 211(2):520-5. PubMed ID: 20400082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
    Meroño T; Brites F; Dauteuille C; Lhomme M; Menafra M; Arteaga A; Castro M; Saez MS; Ballerga EG; Sorroche P; Rey J; Lesnik P; Sordá JA; Chapman MJ; Kontush A; Daruich J
    Clin Sci (Lond); 2015 May; 128(9):609-18. PubMed ID: 25442240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary hemochromatosis in north-eastern Romania.
    Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations.
    Jouanolle AM; Fergelot P; Gandon G; Yaouanq J; Le Gall JY; David V
    Hum Genet; 1997 Oct; 100(5-6):544-7. PubMed ID: 9341868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemochromatosis gene mutations and risk of coronary artery disease.
    Battiloro E; Ombres D; Pascale E; D'Ambrosio E; Verna R; Arca M
    Eur J Hum Genet; 2000 May; 8(5):389-92. PubMed ID: 10854101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.
    Butterworth JR; Cooper BT; Rosenberg WM; Purkiss M; Jobson S; Hathaway M; Briggs D; Howell WM; Wood GM; Adams DH; Iqbal TH
    Gastroenterology; 2002 Aug; 123(2):444-9. PubMed ID: 12145797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of mutations in the hemochromatosis gene with shorter life expectancy.
    Bathum L; Christiansen L; Nybo H; Ranberg KA; Gaist D; Jeune B; Petersen NE; Vaupel J; Christensen K
    Arch Intern Med; 2001 Nov; 161(20):2441-4. PubMed ID: 11700156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.
    Tuomainen TP; Kontula K; Nyyssönen K; Lakka TA; Heliö T; Salonen JT
    Circulation; 1999 Sep; 100(12):1274-9. PubMed ID: 10491370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
    Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.